default author photo

Yuanqing Li

Shenyang Pharmaceutical University

SCHOLARLY PAPERS

2

DOWNLOADS

73

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Discovery of Novel Imidazo[1,2-B]Pyridazine Derivatives as Potent Covalent Inhibitors of Cdk12/13

Number of pages: 40 Posted: 23 Dec 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Wuhan Institute of Technology, Shenyang Pharmaceutical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Wuhan Institute of Technology, Nanjing University of Chinese Medicine (NJUCM) and Chinese Academy of Sciences (CAS) - State Key Laboratory of Drug Research
Downloads 48 (1,086,013)

Abstract:

Loading...

Triple-negative breast cancer, CDK12/13 covalent inhibitors, Cys-1039, THZ531

2.

Targeted isolation of guaiane-type sesquiterpenoids from Daphne Retusa Hemsl. with anti-psoriasis activities using a combination of massive and NPExtractor strategy

Number of pages: 33 Posted: 05 Dec 2025
Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Beijing University of Chinese Medicine, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Independent, Shenyang Pharmaceutical University - Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development and Shenyang Pharmaceutical University - Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development
Downloads 25 (1,385,945)

Abstract:

Loading...

Molecular networking, Daphne Retusa Hemsl., Guaiane-type sesquiterpenoids, Psoriasis